A Multicenter Single-Arm Trial of Neoadjuvant Pyrotinib and Trastuzumab Plus Chemotherapy for HER2-positive Breast Cancer
MEDCOMM(2023)
Key words
HER2-positive breast cancer,multicenter study,neoadjuvant therapy,pyrotinib,trastuzumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined